Over 70 million people in the U.S. are impacted by hearing loss, and age-related hearing loss is the second most common ...
Macquarie Equities cautions that poor US sentiment may continue to weigh on the fortunes of the recovering Cochlear.
Modular Regulatory Strategy Creates Defined Milestone Cadence, Enables Earlier FDA Engagement, and Supports Targeted Final Clinical Module Submission Planned for Q2 2027. White Be ...
Alka Yagnik’s voice has been a constant in so many lives. Her songs aren’t just popular hits they’re memories. Whether it’s ...
Kangdong Kyung Hee University Hospital team links weather patterns and 360,000 cases of sudden sensorineural hearing loss ...
Morning Overview on MSN
The FDA just approved the first-ever gene therapy for inherited hearing loss
Children and adults born with severe hearing loss caused by mutations in the OTOF gene now have a treatment option that did ...
Termination Reflects Company's Confidence in Current Capital PositionWhite Bear Lake, Minnesota--(Newsfile Corp. - June 25, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing ...
After Alka Yagnik revealed she was diagnosed with sensorineural hearing loss following a viral attack, ENT specialist Dr ...
Hereditary hearing loss affects millions globally, with mutations in the SLC26A4 gene among the most common genetic triggers, ...
What is the current share price of Cochlear Limited (COH)? Cochlear Limited's (COH) current share price is $121.75. This constitutes a price movement of 7.95% when compared to the share price 7 days ...
Investors have been buying up struggling companies in the hope of a relief rally. But Matthew Brooks says they’re too early and higher rates will decide the ASX’s path. The worst performing stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results